Randox poslední korporátní člen EDMA

Randox becomes latest corporate member of EDMA

The European Diagnostic Manufacturers Association, EDMA welcomes Randox Laboratories as new corporate affiliate, bringing the Association’s overall membership up to 30 major IVD companies and 21 National Associations. Randox Laboratories’ goal is to continue investing in the development of new healthcare technology solutions to improve disease diagnosis and patient care.

Founded in 1982, Randox Laboratories is an Ulster-based reagent and equipment manufacturer providing a wide range of clinical diagnostic products for laboratory medicine. The company’s core products and services include Biochip Array Technology, clinical chemistry automation systems, external quality assurance schemes, Internet driven QA systems, quality control materials, antibodies, recombinant proteins, clinical reagents and environmental diagnostics.

With sales and distribution agreements in 130 countries and having international offices with representation in the continents of Africa, Asia, Australia, Europe, North America and South America, Randox Laboratories employs over 600 people, including 185 research scientists, and invest approximately 30% of gross income in research and development.

EDMA looks forward to a fruitful cooperation with Randox Laboratories to promote In Vitro testing, prevention, early diagnosis and monitoring of treatments, access to innovation, and high quality healthcare.

Background:
EDMA, the European Diagnostic Manufacturers Association represents National Associations and major companies engaged in the research, development, manufacture or distribution of In Vitro Diagnostic (IVD) medical devices in Europe. Through its affiliated National Associations, EDMA represents in total more than 500 companies (or over 700 legal entities) across Europe. The mission of EDMA is to raise awareness of the importance, usefulness and added-value that diagnostic information can provide to healthcare. For this purpose, EDMA cooperates with European institutions, patients groups, trade associations, health professionals and academia to support an appropriate regulatory system, to work towards a realistic economic environment for healthcare in Europe and to be an effective voice in globalisation.
For more information, please visit EDMA website or contact:
Gloria Galán, EDMA Communications & Public Affairs Manager (Tel. +32 2 777 02 77)